Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-24

Clinical Trial Update: Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder

View source ↗

Summary

An observational clinical trial update evaluating how oral cariprazine affects disease activity in adults with Bipolar I Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cariprazine (Vraylar) (cariprazine)

Snippet

Sponsor: AbbVie | Conditions: Bipolar I Disorder | Status: COMPLETED